PURPOSE: Prospective data to examine the association of homocysteine with age-related macular degeneration (AMD) are limited. We examined the prospective relation of plasma homocysteine level and AMD in a large cohort of apparently healthy women. METHODS: We evaluated the relationship between baseline levels of plasma homocysteine and incident AMD among 27,479 female health professionals aged 40 years or older. Main outcome measures were total AMD, defined as self-report documented by medical record evidence of an initial diagnosis after randomization, and visually significant AMD, defined as confirmed incident AMD with visual acuity 20/30 or worse attributable to this condition. RESULTS: During an average 10 years of follow-up, a total of 452 cases of AMD, including 182 cases of visually significant AMD, were documented. Women in the highest versus lowest quartile of plasma homocysteine had modestly, but statistically non-significant, increased risks of total AMD (hazard ratio, HR, 1.24, 95% confidence interval, CI, 0.95-1.63; p for trend 0.07) and visually significant AMD (HR 1.41, 95% CI 0.92-2.17; p for trend 0.052) in age- and treatment-adjusted analyses. CONCLUSIONS: These prospective data from a large cohort of apparently healthy women do not support a strong role for homocysteine in AMD occurrence.
RCT Entities:
PURPOSE: Prospective data to examine the association of homocysteine with age-related macular degeneration (AMD) are limited. We examined the prospective relation of plasma homocysteine level and AMD in a large cohort of apparently healthy women. METHODS: We evaluated the relationship between baseline levels of plasma homocysteine and incident AMD among 27,479 female health professionals aged 40 years or older. Main outcome measures were total AMD, defined as self-report documented by medical record evidence of an initial diagnosis after randomization, and visually significant AMD, defined as confirmed incident AMD with visual acuity 20/30 or worse attributable to this condition. RESULTS: During an average 10 years of follow-up, a total of 452 cases of AMD, including 182 cases of visually significant AMD, were documented. Women in the highest versus lowest quartile of plasma homocysteine had modestly, but statistically non-significant, increased risks of total AMD (hazard ratio, HR, 1.24, 95% confidence interval, CI, 0.95-1.63; p for trend 0.07) and visually significant AMD (HR 1.41, 95% CI 0.92-2.17; p for trend 0.052) in age- and treatment-adjusted analyses. CONCLUSIONS: These prospective data from a large cohort of apparently healthy women do not support a strong role for homocysteine in AMD occurrence.
Authors: Jie Jin Wang; Robert J Ross; Jingsheng Tuo; George Burlutsky; Ava G Tan; Chi-Chao Chan; Emmanuel J Favaloro; Andrew Williams; Paul Mitchell Journal: Ophthalmology Date: 2007-08-02 Impact factor: 12.079
Authors: Kathy H C Wu; Ava Grace Tan; Elena Rochtchina; Emmanuel J Favaloro; Andrew Williams; Paul Mitchell; Jie Jin Wang Journal: Invest Ophthalmol Vis Sci Date: 2007-05 Impact factor: 4.799
Authors: E Cho; S Hung; W C Willett; D Spiegelman; E B Rimm; J M Seddon; G A Colditz; S E Hankinson Journal: Am J Clin Nutr Date: 2001-02 Impact factor: 7.045
Authors: Bamini Gopinath; Victoria M Flood; Elena Rochtchina; Jie Jin Wang; Paul Mitchell Journal: Am J Clin Nutr Date: 2013-05-01 Impact factor: 7.045
Authors: Christine M Albert; Nancy R Cook; J Michael Gaziano; Elaine Zaharris; Jean MacFadyen; Eleanor Danielson; Julie E Buring; JoAnn E Manson Journal: JAMA Date: 2008-05-07 Impact factor: 56.272
Authors: Orhan Ates; Sedat Azizi; H Hakan Alp; Ahmet Kiziltunc; Sukru Beydemir; Emine Cinici; Ibrahim Kocer; Orhan Baykal Journal: Tohoku J Exp Med Date: 2009-01 Impact factor: 1.848
Authors: Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati Journal: Prog Retin Eye Res Date: 2016-05-06 Impact factor: 21.198
Authors: William G Christen; Nancy R Cook; Stephanie E Chiuve; Paul M Ridker; J Michael Gaziano Journal: Ophthalmic Epidemiol Date: 2017-10-16 Impact factor: 1.648
Authors: William G Christen; Daniel I Chasman; Nancy R Cook; Stephanie E Chiuve; Paul M Ridker; Julie E Buring Journal: Ophthalmol Retina Date: 2018-05